News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
859,545 Results
Type
Article (87345)
Company Profile (759)
Press Release (771416)
Multimedia
Podcasts (168)
Webinars (27)
Section
Business (233019)
Career Advice (4137)
Deals (39786)
Drug Delivery (134)
Drug Development (91232)
Employer Resources (202)
FDA (18267)
Job Trends (17394)
News (397306)
Policy (39917)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (123)
Alliances (56979)
ALS (140)
Alzheimer's disease (1669)
Antibody-drug conjugate (ADC) (217)
Approvals (18276)
Artificial intelligence (470)
Autoimmune disease (64)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (157)
Biotechnology (484)
Bladder cancer (122)
Brain cancer (50)
Breast cancer (466)
Cancer (3715)
Cardiovascular disease (330)
Career advice (3552)
Career pathing (37)
CAR-T (237)
CDC (52)
Cell therapy (653)
Cervical cancer (32)
Clinical research (75160)
Collaboration (1336)
Company closure (4)
Compensation (911)
Complete response letters (59)
COVID-19 (2946)
CRISPR (80)
C-suite (549)
Cystic fibrosis (132)
Data (4079)
Decentralized trials (2)
Denatured (60)
Depression (108)
Diabetes (442)
Diagnostics (7075)
Digital health (34)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (226)
Drug pricing (178)
Drug shortages (36)
Duchenne muscular dystrophy (194)
Earnings (98695)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132630)
Executive appointments (970)
FDA (20624)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (13)
Funding (1202)
Gene editing (167)
Generative AI (45)
Gene therapy (517)
GLP-1 (1007)
Government (5370)
Grass and pollen (7)
Guidances (335)
Healthcare (20937)
HIV (48)
Huntington's disease (36)
IgA nephropathy (55)
Immunology and inflammation (238)
Immuno-oncology (19)
Indications (51)
Infectious disease (3176)
Inflammatory bowel disease (182)
Inflation Reduction Act (15)
Influenza (92)
Intellectual property (180)
Interviews (815)
IPO (17923)
IRA (59)
Job creations (5196)
Job search strategy (2864)
Kidney cancer (15)
Labor market (74)
Layoffs (634)
Leadership (31)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (531)
Lymphoma (256)
Machine learning (26)
Management (66)
Manufacturing (608)
MASH (129)
Medical device (14852)
Medtech (14873)
Mergers & acquisitions (22711)
Metabolic disorders (1122)
Multiple sclerosis (133)
NASH (23)
Neurodegenerative disease (213)
Neuropsychiatric disorders (59)
Neuroscience (2654)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (56)
Obesity (551)
Opinion (308)
Ovarian cancer (122)
Pain (160)
Pancreatic cancer (163)
Parkinson's disease (231)
Partnered (28)
Patents (402)
Patient recruitment (293)
Peanut (57)
People (66166)
Pharmaceutical (144)
Pharmacy benefit managers (26)
Phase I (23167)
Phase II (32639)
Phase III (24560)
Pipeline (2594)
Policy (288)
Postmarket research (3554)
Preclinical (10458)
Press Release (72)
Prostate cancer (187)
Psychedelics (51)
Radiopharmaceuticals (281)
Rare diseases (639)
Real estate (7420)
Recruiting (78)
Regulatory (27873)
Reports (64)
Research institute (2688)
Resumes & cover letters (650)
Rett syndrome (13)
RNA editing (15)
RSV (69)
Schizophrenia (128)
Series A (198)
Series B (148)
Service/supplier (30)
Sickle cell disease (78)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (98)
Tariffs (89)
The Weekly (106)
Vaccines (1025)
Venture capital (66)
Weight loss (385)
Women's health (57)
Worklife (21)
Date
Today (32)
Last 7 days (584)
Last 30 days (2217)
Last 365 days (33569)
2025 (25084)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (79)
Alaska (7)
Arizona (299)
Arkansas (14)
Asia (50875)
Australia (8938)
California (9169)
Canada (2793)
China (862)
Colorado (390)
Connecticut (409)
Delaware (251)
Europe (116893)
Florida (1350)
Georgia (308)
Hawaii (3)
Idaho (67)
Illinois (800)
India (47)
Indiana (446)
Iowa (19)
Japan (298)
Kansas (123)
Kentucky (36)
Louisiana (20)
Maine (76)
Maryland (1243)
Massachusetts (6904)
Michigan (306)
Minnesota (552)
Mississippi (4)
Missouri (115)
Montana (33)
Nebraska (26)
Nevada (106)
New Hampshire (76)
New Jersey (2541)
New Mexico (32)
New York (2507)
North Carolina (1387)
North Dakota (10)
Northern California (4100)
Ohio (286)
Oklahoma (20)
Oregon (50)
Pennsylvania (1915)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (46)
South Dakota (1)
Southern California (3506)
Tennessee (148)
Texas (1436)
United States (33998)
Utah (272)
Virginia (243)
Washington D.C. (82)
Washington State (792)
West Virginia (4)
Wisconsin (95)
Wyoming (1)
There are 859,545 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Cell and Gene Therapy
Meeting on the Mesa Arrives Amid Mixed Signals for Cell and Gene Therapy
As industry leaders gather at the annual event in Phoenix, the cell and gene therapy space remains in a state of flux, with M&A activity and regulatory support signaling momentum while commercialization challenges continue to hinder broader investor interest.
October 6, 2025
·
5 min read
·
Ben Hargreaves
Opinion
Gene Therapy’s Future Hinges on the Economics of Safety
Smarter design through targeted delivery and human-relevant testing can save the industry from costly safety failures.
October 6, 2025
·
7 min read
·
Ronald A. Li
Multiple sclerosis
Beyond BTK Inhibitors: Next Gen MS Treatments Could Transcend Symptom Management
While Bruton’s tyrosine kinase inhibitors are often hailed as the next big breakthrough in multiple sclerosis, Immunic Therapeutics and others are leveraging neuroprotective targets and remyelination to keep the disease at bay.
October 6, 2025
·
5 min read
·
Ben Hargreaves
Press Releases
Radiant Biotherapeutics to Present Next-Generation Multabody™ Approach for Cancer Immunotherapy at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting
October 5, 2025
·
2 min read
Press Releases
Smith+Nephew announce latest scientific data supporting new ALLEVYN™ COMPLETE CARE 5-Layer Foam Dressing for pressure injury prevention
October 5, 2025
·
6 min read
Press Releases
Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2025
October 5, 2025
·
1 min read
Press Releases
Frontier Medicines Announces Publication in Structure Highlighting Novel E3 Ligase DCAF2 can be Harnessed for Targeted Protein Degradation
October 5, 2025
·
2 min read
Press Releases
Aspire Biopharma to Present at Noble Capital Markets 2025 Emerging Growth Virtual Equity Conference - October 8-9, 2025
October 5, 2025
·
5 min read
Press Releases
A2 Bio to Present Early Safety and Efficacy Data from EVEREST-2 Study during 2025 Annual Meeting of the Society for Immunotherapy of Cancer
October 5, 2025
·
4 min read
Press Releases
Aulos Bioscience to Present Updated Phase 2 Data for Imneskibart (AU-007) in Melanoma and Non-Small Cell Lung Cancer at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 5, 2025
·
2 min read
1 of 85,955
Next
